Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03921879
Title Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncotartis, Inc.
Indications

peripheral T-cell lymphoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

OT-82

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.